Instrumentation Laboratory Company - Product Pipeline Analysis, 2018 Update

  • ID: 4050673
  • Company Profile
  • 76 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Abbott Point of Care Inc
  • Daxor Corp
  • Diamond Diagnostics
  • Haemonetics Corp
  • Hemagen Diagnostics Inc
  • Sysmex America Inc
  • MORE
Summary

Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories. Its major products include critical care systems including whole blood analyzers, CO-Oximeter and whole-blood coagulation system; hemostasis systems including testing systems, reagents, controls and calibrators; and information management systems. IL also offers various quality control products; and services such as advanced automation, quality management, clinical support and product support. The company offers its products to hospitals and independent clinical laboratories the world over. IL is headquartered in Bedford, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Instrumentation Laboratory Company
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Point of Care Inc
  • Daxor Corp
  • Diamond Diagnostics
  • Haemonetics Corp
  • Hemagen Diagnostics Inc
  • Sysmex America Inc
  • MORE
  • Instrumentation Laboratory Company Overview
  • Instrumentation Laboratory Company Snapshot
  • Instrumentation Laboratory Company Pipeline Products and Ongoing Clinical Trials Overview
  • Instrumentation Laboratory Company - Pipeline Analysis Overview
  • Business Description
  • Instrumentation Laboratory Company - Key Facts
  • Instrumentation Laboratory Company - Major Products and Services
  • Instrumentation Laboratory Company Pipeline Products by Development Stage
  • Instrumentation Laboratory Company Pipeline Products Overview
  • ACL AcuStar - aß2GPI Domain I Assay
  • ACL AcuStar - aß2GPI Domain I Assay Product Overview
  • ACL AcuStar - HIT IgG Test
  • ACL AcuStar - HIT IgG Test Product Overview
  • ACL AcuStar - HIT Total ab Test
  • ACL AcuStar - HIT Total ab Test Product Overview
  • ACL AcuStar - VWF: RCo Assay
  • ACL AcuStar - VWF: RCo Assay Product Overview
  • ACL AcuStar - VWF:Ag Assay
  • ACL AcuStar - VWF:Ag Assay Product Overview
  • ACL TOP 300 CTS System - Apixaban Test
  • ACL TOP 300 CTS System - Apixaban Test Product Overview
  • ACL TOP 300 CTS System - Dabigatran Test
  • ACL TOP 300 CTS System - Dabigatran Test Product Overview
  • ACL TOP 300 CTS system - Global Protein C Pathway Test
  • ACL TOP 300 CTS system - Global Protein C Pathway Test Product Overview
  • ACL TOP 300 CTS System - HIT Assay
  • ACL TOP 300 CTS System - HIT Assay Product Overview
  • ACL TOP 300 CTS System - Rivaroxaban Test
  • ACL TOP 300 CTS System - Rivaroxaban Test Product Overview
  • ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay
  • ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay Product Overview
  • ACL TOP 350 CTS System - Apixaban Test
  • ACL TOP 350 CTS System - Apixaban Test Product Overview
  • ACL TOP 350 CTS System - Dabigatran Test
  • ACL TOP 350 CTS System - Dabigatran Test Product Overview
  • ACL TOP 350 CTS System - Rivaroxaban Test
  • ACL TOP 350 CTS System - Rivaroxaban Test Product Overview
  • ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay
  • ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
  • ACL TOP 500 CTS System - Apixaban Test
  • ACL TOP 500 CTS System - Apixaban Test Product Overview
  • ACL TOP 500 CTS System - Dabigatran Test
  • ACL TOP 500 CTS System - Dabigatran Test Product Overview
  • ACL TOP 500 CTS System - Global Protein C Pathway Test
  • ACL TOP 500 CTS System - Global Protein C Pathway Test Product Overview
  • ACL TOP 500 CTS System - HIT Test
  • ACL TOP 500 CTS System - HIT Test Product Overview
  • ACL TOP 500 CTS System - Rivaroxaban Test
  • ACL TOP 500 CTS System - Rivaroxaban Test Product Overview
  • ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay
  • ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
  • ACL TOP 550 CTS System - Apixaban Test
  • ACL TOP 550 CTS System - Apixaban Test Product Overview
  • ACL TOP 550 CTS System - Dabigatran Test
  • ACL TOP 550 CTS System - Dabigatran Test Product Overview
  • ACL TOP 550 CTS System - Rivaroxaban Test
  • ACL TOP 550 CTS System - Rivaroxaban Test Product Overview
  • ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay
  • ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
  • ACL TOP 700 - HIT Test
  • ACL TOP 700 - HIT Test Product Overview
  • ACL TOP 700 CTS System - VWF Ristocetin Cofactor Activity Assay
  • ACL TOP 700 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
  • ACL TOP 700 System - Apixaban Test
  • ACL TOP 700 System - Apixaban Test Product Overview
  • ACL TOP 700 System - Dabigatran Test
  • ACL TOP 700 System - Dabigatran Test Product Overview
  • ACL TOP 700 System - Global Protein C Pathway Test
  • ACL TOP 700 System - Global Protein C Pathway Test Product Overview
  • ACL TOP 700 System - Rivaroxaban Test
  • ACL TOP 700 System - Rivaroxaban Test Product Overview
  • ACL TOP 750 CTS System - Apixaban Test
  • ACL TOP 750 CTS System - Apixaban Test Product Overview
  • ACL TOP 750 CTS System - Dabigatran Test
  • ACL TOP 750 CTS System - Dabigatran Test Product Overview
  • ACL TOP 750 CTS System - Rivaroxaban Test
  • ACL TOP 750 CTS System - Rivaroxaban Test Product Overview
  • ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay
  • ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
  • Dabigatran Direct Thrombin Inhibitor Assay
  • Dabigatran Direct Thrombin Inhibitor Assay Product Overview
  • GEM Premier 4000 Analyzer - BUN
  • GEM Premier 4000 Analyzer - BUN Product Overview
  • GEM Premier 4000 Analyzer - tCO2 Test
  • GEM Premier 4000 Analyzer - tCO2 Test Product Overview
  • HemoSIL ACL AcuStar - VWF:CB Assay
  • HemoSIL ACL AcuStar - VWF:CB Assay Product Overview
  • HemosIL Acustar HIT-Ab (PF4-H) Assay
  • HemosIL Acustar HIT-Ab (PF4-H) Assay Product Overview
  • HemosIL AcuStar Multi-Ab Controls
  • HemosIL AcuStar Multi-Ab Controls Product Overview
  • HemosIL Apixaban Testing Assay
  • HemosIL Apixaban Testing Assay Product Overview
  • HemosIL Dabigatran Calibrators
  • HemosIL Dabigatran Calibrators Product Overview
  • HemosIL Dabigatran Controls
  • HemosIL Dabigatran Controls Product Overview
  • HemosIL Rivaroxaban Calibrators
  • HemosIL Rivaroxaban Calibrators Product Overview
  • POC Enzymatic Creatinine Assay
  • POC Enzymatic Creatinine Assay Product Overview
  • Rivaroxaban Liquid Anti-Xa Assay
  • Rivaroxaban Liquid Anti-Xa Assay Product Overview
  • Instrumentation Laboratory Company - Key Competitors
  • Instrumentation Laboratory Company - Key Employees
  • Instrumentation Laboratory Company - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Instrumentation Laboratory Company, Recent Developments
  • May 07, 2018: Instrumentation Laboratory Worldwide Sales Top $970 M In 2017
  • Oct 16, 2017: Instrumentation Laboratory Receives US FDA Clearance For HemosIL AcuStar HIT-IgG(PF4-H) Assay And Controls
  • Jul 31, 2017: Instrumentation Laboratory Launches GEMweb Plus 500 Custom Connectivity Worldwide
  • Apr 04, 2017: Instrumentation Laboratory Achieves Record Worldwide Sales In 2016
  • Dec 19, 2016: Instrumentation Laboratory Receives US FDA Clearance For New GEM Premier 5000 Critical Care Testing System
  • Oct 11, 2016: Instrumentation Laboratory Launches HemosIL AcuStar VWF:CB Assay In Europe And Other International Markets
  • Sep 26, 2016: Instrumentation Laboratory Launches HemoHub Intelligent Data Manager Worldwide
  • Aug 15, 2016: Instrumentation Laboratory Launches HemosIL ReadiPlasTin Assay Worldwide
  • Aug 15, 2016: Instrumentation Laboratory Launches HemosIL ReadiPlasTin Assay Worldwide
  • Aug 11, 2016: Instrumentation Laboratory Presents New Innovations In Hemostasis At AACC Annual Meeting
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sysmex America Inc
  • Hemagen Diagnostics Inc
  • Haemonetics Corp
  • Diamond Diagnostics
  • Daxor Corp
  • Abbott Point of Care Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll